Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-06

FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (Leading Pharma, LLC)

View source ↗

Summary

FDA approved Leading Pharma, LLC's original Abbreviated New Drug Application for oxybutynin chloride, enabling a generic version of this antimuscarinic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

ORIG AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)